🔎 Trials Near Me

Gara Jalqabaatti › Dhukkuba Kroonii › Indiana › Indianapolis

Qorannoo klinikaalii Dhukkuba Kroonii Indianapolis, IN keessatti

Qorannoo 10 Dhukkuba Kroonii f Indianapolis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Namoota walitti qabaa jiraSadarkaa 3
  • Indiana University Health University Hospital ( Site 5022), Indianapolis
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Indiana University Health University Hospital /ID# 278129, Indianapolis
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06548542

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2/3
  • IU Health University Hospital, Indianapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07196722

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Namoota walitti qabaa jiraSadarkaa 3
  • Riley Hospital for Children, Indianapolis
Umuriin 3 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06663332

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • Indiana University Health University Hospital, Indianapolis
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Indiana University Health Riley Hospital for Children /ID# 256454, Indianapolis
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05995353

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Riley Childrens Hospital, Indianapolis
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05509777

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Indiana University Health Riley Hospital for Children /ID# 262215, Indianapolis
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 4
  • Riley Hospital for Children at Indiana University Health, Indianapolis
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT05781152

Precise Infliximab Exposure and Pharmacodynamic Control

Namoota walitti qabaa jiraSadarkaa 2/3
  • Riley Hospital for Children, Indianapolis
Umuriin 6 hanga 22 · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT05660746

Qorannoo Dhukkuba Kroonii magaalota biroo keessatti

Qorannoo biroo Indianapolis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.